Despite these obstacles, in the present study, both approaches, the semiquantitative and the quantitative, were utilized in an attempt to investigate the predictive role of “full” quantitative 18F-FDG PET/CT analysis on the survival of metastatic melanoma patients treated with PD-1 blockade. This evidence concerns the gene PDCD1 and metastatic melanoma.